glp 1 agonists for type 2 diabetes GLP-1 receptor and beyond. Part 1: benefits in A clinician's perspective 📝 GLP-1

The FDA has issued specific warnings about compounded semaglutide products, particularly those using semaglutide sodium salt, which may contain impurities, incorrect dosages, or entirely different substances than labeled

Keeping detailed notes of your reconstitution math prevents dosing errors

doi: 10.1002/jnr.24781 71 LimJWLeeJPaeAN

Most GLP-1 medications are given via subcutaneous injection, which means an injection under the skin but not in the muscle

Therefore, the regulation of the activity of microglia is believed to play a key role in the neuroinflammation of PD

According to a 2024 study by Duo Do et al., reported that the use of a once-weekly GLP-1 receptor agonist was independently linked to a 30.5% higher prevalence of elevated residual gastric content on preprocedural gastric ultrasonography, which is a significant risk factor for aspiration during anesthesia